| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 2017-12-31 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-12-31 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 2016-12-31 |
| Chairman | 46 | 2019-12-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.35% | +1.36% | +45.38% | +140.47% | 1,280B | |
| -0.13% | +1.48% | +44.67% | +90.43% | 675B | |
| +0.37% | +0.05% | +31.00% | +112.84% | 521B | |
| +0.91% | +3.50% | +39.60% | +69.80% | 386B | |
| -0.59% | -2.11% | +61.83% | +45.16% | 363B | |
| +1.39% | +0.39% | +28.60% | +59.11% | 301B | |
| +0.89% | -0.22% | +3.64% | +36.71% | 286B | |
| +0.62% | -2.17% | +38.31% | +75.12% | 253B | |
| -0.67% | -2.72% | +38.49% | +123.56% | 211B | |
| Average | +0.47% | -0.51% | +36.84% | +83.69% | 475B | |
| Weighted average by Cap. | +0.79% | +0.20% | +39.66% | +97.36% |
Employees
4
Sector
Pharmaceuticals
